|
On (b)(6) 2025, fujifilm healthcare americas corporation was informed by fujifilm medwork gmbh of the reportable event involving val1-g7-50 from the manufacturer.During an fda-inspection on (b)(6) 2025, it was found that complaint involving the val1-g7-50 was not evaluated for reportability to the fda.Therefore, val1-g7-50 complaint received prior to the inspection was evaluated for fda mdr.Fujifilm medwork gmbh received this complaint on (b)(6) 2022, and on (b)(6) 2025, determined it to be reportable (mdr 3020707080-2025-00003 submitted on (b)(6) 2025).The problem only occurred with the last batch delivered of fujifilm valves val1-g7-50, qty - 10, used with fujifilm endoscope, where no products can be pushed through the opening without perforating the frog.No patient injury was reported.
|